Patents by Inventor Jared E. TOETTCHER

Jared E. TOETTCHER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11859223
    Abstract: A system and method for controlling metabolic enzymes or pathways in cells to produce a chemical above the levels of a wild-type strain is disclosed. The system utilizes cells, including yeasts, bacteria, and molds, having at least two genes capable of being controlled bi-directionally with light, where one gene is turned from off to on when exposed to light and another gene is turned from on to off when exposed to light, the two genes reversing when the light is turned off. Cells may utilize any number of sequences that benefit chemical production, including sequences that: encode for constitutive transcription of light-activated transcription factor fusions; encode for a metabolic enzyme; encode for a repressor; induce expression of metabolic enzymes; and an endogenous or exogenous activator expressed by a constitutive promoter, inducible promoter, or gene circuit.
    Type: Grant
    Filed: April 7, 2017
    Date of Patent: January 2, 2024
    Assignee: THE TRUSTEES OF PRINCETON UNIVERSITY
    Inventors: Jose L. Avalos, Jared E. Toettcher, Evan M. Zhao
  • Publication number: 20230212626
    Abstract: Disclosed is a technique for constructing optogenetic amplifier and inverter circuits utilizing transcriptional activator/repressor pairs, in which expression of the transcriptional activator or repressor, respectively, is controlled by light-controlled transcription factors. This system is demonstrated utilizing the quinic acid regulon system from Neurospora crassa, or Q System, a transcriptional activator/repressor system. This is also demonstrated utilizing the galactose regulon from Saccharomyces cerevisiae, or GAL System. Such optogenetic amplifier circuits enable multi-phase microbial fermentations, in which different light schedules are applied in each phase to dynamically control different metabolic pathways for the production of proteins, fuels or chemicals.
    Type: Application
    Filed: December 22, 2022
    Publication date: July 6, 2023
    Applicant: The Trustees of Princeton University
    Inventors: Jose L. Avalos, Jared E. Toettcher, Evan M. Zhao, Makoto A. Lalwani
  • Publication number: 20210062165
    Abstract: Provided herein is a system and method of optogenetically inducibly clustering metabolic enzymes for the production of chemicals using cell factories. More particularly, the described inducible protein clustering approach clusters metabolic enzymes by, e.g., a change in illumination conditions (either a switch from dark to light or from light to dark). Performing this clustering leads to an increase in the production of metabolites by the clustered enzymes. In some embodiments, a light-sensitive domain may be replaced with any inducible domain.
    Type: Application
    Filed: August 26, 2020
    Publication date: March 4, 2021
    Applicant: The Trustees of Princeton University
    Inventors: Jose L. Avalos, Jared E. Toettcher, Clifford P. Brangwynne, Evan M. Zhao, Maxwell Z. Wilson
  • Publication number: 20190119331
    Abstract: A system and method for controlling metabolic enzymes or pathways in cells to produce a chemical above the levels of a wild-type strain is disclosed. The system utilizes cells, including yeasts, bacteria, and molds, having at least two genes capable of being controlled bi-directionally with light, where one gene is turned from off to on when exposed to light and another gene is turned from on to off when exposed to light, the two genes reversing when the light is turned off. Cells may utilize any number of sequences that benefit chemical production, including sequences that: encode for constitutive transcription of light-activated transcription factor fusions; encode for a metabolic enzyme; encode for a repressor; induce expression of metabolic enzymes; and an endogenous or exogenous activator expressed by a constitutive promoter, inducible promoter, or gene circuit.
    Type: Application
    Filed: April 7, 2017
    Publication date: April 25, 2019
    Applicant: The Trustees of Princeton University
    Inventors: Jose L. AVALOS, Jared E. TOETTCHER, Evan M. ZHAO